OR WAIT null SECS
© 2023 MJH Life Sciences and Consultant Live. All rights reserved.
Clinical Assistant Professor
University of Illinois
Director of Clinical Research
University Retina and Macula Associates
November 13, 2023
Veeral Sheth, MD, MBA discusses the 3 improvements needed for the future of treating patients with geographic atrophy.
Veeral Sheth, MD, MBA, discusses the clinical trial data that led to FDA approval of SYFOVRE and IZERVAY for geographic atrophy.
Veeral Sheth, MD discusses the two newly FDA-approved therapies for geographic atrophy: pegcetacoplan injection (SYFOVRE) and avacincaptad pegol (IZERVAY).
Veeral Sheth, MD, MBA describes the presentation of geographic atrophy in patients and how they are first affected by the disease.